A retrospective study of retention of opioid-dependent adolescents and young adults in an outpatient buprenorphine/naloxone clinic

Journal of Addiction Medicine

Volumn 8, Issue 3, 2014, Pages 176-182

  Matson, Steven C ^a,b   Hobson, Gerrit ^c   Abdel Rasoul, Mahmoud ^d   Bonny, Andrea E ^a,b,c  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

Adolescence; Buprenorphine; Opioid dependence; Outpatient treatment

Indexed keywords

BUPRENORPHINE; NALOXONE; NARCOTIC ANTAGONIST;

ADOLESCENT; FEMALE; HEROIN DEPENDENCE; HUMAN; MALE; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PATIENT COMPLIANCE; RETROSPECTIVE STUDY; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA; SUBSTANCE ABUSE; YOUNG ADULT;

ADOLESCENT; BUPRENORPHINE; FEMALE; HEROIN DEPENDENCE; HUMANS; MALE; NALOXONE; NARCOTIC ANTAGONISTS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; SEX FACTORS; SUBSTANCE ABUSE DETECTION; YOUNG ADULT;

EID: 84905856509     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0000000000000035     Document Type: Article

References (23)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. Washington, DC: American Psychiatric Association, 2000.
2. American Society of Addiction Medicine. ASAM Patient Placement Criteria for the Treatment of Substance-Related Disorders. Chevy Chase, MD: American Society of Addiction Medicine, 2001.
3. Armstrong G, Kermode M, Sharma C, et al. Opioid substitution therapy in Manipur and Nagaland, North-east India: operational research in action. Harm Reduct J 2010;7:29.
4. Barnett PG, Rogers JH, Bloch DA. A meta-analysis comparing the effectiveness of buprenorphine to methadone for treatment of opioid dependence. Addiction 2001;96:683-690.
5. Dole VO. Implications of methadone maintenance for theories of narcotic addiction. JAMA 1988;260:3025-3029.
6. Fiellin DA, Moore BA, Sullivan LE, et al. Long-term treatment with buprenor-phine/naloxone in primary care: results at 2-5 years. Am J Addict 2008;17:116-120.
7. Fiellin DA, Pantalon MV, Chawarski MC, et al. Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence. N Engl J Med 2006;355:365-374.
8. Hunt GH, Odoroff ME. Followup study of narcotic drug addicts after hospi-talization. Public Health Rep 1962;77:41-54.
9. Jerry JM, Collins GB. Medication-assisted treatment of opioid dependence is gaining favor. Cleve Clin J Med 2013;80:345-349.
10. Johnston LD, O'Malley PM, Bachman JG, et al. Monitoring the Future National Results on Drug Use: 2012 Overview, Key Findings on Adolescent Drug Use. Ann Arbor, MI: Institute for Social Research, The University of Michigan, 2013.
11. Kosten TR, Gorelick DA. The Lexington narcotic farm. Am J Psychiatry 2002;159:22.
12. Marsch L, Bickel WK, Badger GJ, et al. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial. AMA Arch Gen Psychiatry 2005;62:1157-1164.
13. Mintzer I, Eisenberg M, Terra M, et al. Treating opioid addiction with buprenorphine-naloxone in community-based primary care settings. Ann Fam Me d 2007;5:146-150.
14. Moore BA, Fiellin DA, Barry DT, et al. Primary care office-based buprenor-phine treatment: comparison of heroin and prescription opioid dependent patients. J Gen Intern Med 2007;22:527-530.
15. O'Connor PG, Oliveto AH, Shi JM, et al. A pilot study of primary-care-based buprenorphine maintenance for heroin dependence. Am J Drug Alcohol Abuse 1996;22:523-531.
16. Parran TV, Adelman CA, Merkin B, et al. Long-term outcomes of office-based buprenorphine/naloxone maintenance therapy.Drug Alcohol Depend 2010;48:56-60.
17. Smyth BP, Fagan J, Kernan K. Outcome of heroin-dependent adolescents presenting for opioid substitution treatment. J Subst Abuse Treat 2012;42: 35-44.
18. Subramaniam G, Warden D, Minhajuddin A, et al. Predictors of abstinence: National Institute of Drug Abuse multisite buprenorphine/naloxone treatment trial in opioid-dependent youth. J Am Acad Child Adolesc Psychiatry 2011;50:1120-1128.
19. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. Treatment Episode Data Set (TEDS): 2000-2010. National Admissions to Substance Abuse Treatment Services. DASIS Series S-61, HHS Publication No. (SMA) 12-4701. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2012.
20. Tkacz J, Severt J, Cacciola J, et al. Compliance with buprenorphine medication-assisted treatment and relapse to opioid use. Am J Addict 2012;21:55-62.
21. Warden D, Subramaniam GA, Carmody T, et al. Predictors of attrition with buprenorphine/naloxone treatment in opioid dependent youth. Addict Be-hav 2012;37:1046-1053.
22. West SL, O'Neal KK, Graham CW. A meta-analysis comparing the effectiveness of buprenorphine and methadone. J Subst Abuse 2000;12:405-414.
23. Woody G, Poole SA, Subramaniam G, et al. Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial. JAMA 2008;300:2003-2011.